Fancin

Quick links to important sections

Fancin

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fancin

Property Description
Active ingredient Tinidazole
Form Oral Tablet
Pharmacological Class Antimicrobial Agent / Nitroimidazole
General Purpose Resolving infections caused by specific pathogens
Origin Synthetic

What Type of Medicine is Fancin?

Fancin is a synthetic, prescription-only medication whose single active ingredient is Tinidazole (INN), a compound and a potent antimicrobial agent. Pharmacologically, it is classified as an Antimicrobial agent, specifically belonging to the Nitroimidazole class of compounds. This chemical classification defines Fancin as a substance used for systemic treatment against specific protozoa and bacteria that thrive in low-oxygen conditions (anaerobes). Tinidazole is recognized for its extended half-life compared to other Nitroimidazoles, a feature often considered for specific treatment regimens.


Composition and Physical Form of Fancin

Fancin is formulated as an oral tablet, designed for systemic administration throughout the body. The composition is centered on the Tinidazole molecule, a derivative of the synthetic imidazole chemical family, ensuring a consistent and standardized product. Tinidazole is an established antimicrobial effective against anaerobic pathogens. As a single-ingredient product, the tablet consists only of the active Tinidazole substance combined with necessary inert solid pharmaceutical excipients (binders, fillers) that facilitate its structure and controlled absorption when swallowed.


Fancin's General Purpose and Principle of Action

The general purpose of Fancin is to help resolve infections by eliminating the responsible pathogens, such as treating a common protozoal infection in the gastrointestinal tract. This is achieved through a principle of selective toxicity: the drug is absorbed by the target organisms, such as protozoa and anaerobic bacteria, where it is chemically activated. This activation generates compounds that cause irreversible damage to the organism's DNA and essential components, effectively halting their growth and leading to their destruction. This selective action is fundamental to its effectiveness as an essential medicine. The systemic use of the tablet allows the drug to address infections located within various tissues and organ systems.

Regulatory References

  1. verified by the U.S. National Library of Medicine
  2. World Health Organization Model List of Essential Medicines

What side effects are possible with Fancin?

Possible Side Effects and Safety Information

Fancin, a sympathomimetic amine, may cause side effects due to its stimulant properties. Patients should be aware of potential adverse reactions, particularly those affecting the cardiovascular and central nervous systems, and understand the contraindications before starting treatment.


Common and Serious Side Effects

Commonly reported side effects often include dry mouth, insomnia, dizziness, restlessness, euphoria, unpleasant taste, and gastrointestinal disturbances such as constipation or diarrhea. Some patients may also experience a rapid heart rate (tachycardia) or elevated blood pressure.

Serious side effects warranting immediate medical attention include signs of an allergic reaction (e.g., hives, swelling of the face, tongue, or throat), chest pain or pressure, shortness of breath, fainting, and symptoms indicative of a serious increase in blood pressure or heart problem (e.g., severe headache, slurred speech).


Safety and Contraindications

Fancin is contraindicated in patients with a history of cardiovascular disease (including moderate to severe hypertension, symptomatic cardiovascular disease, or advanced arteriosclerosis), hyperthyroidism, glaucoma, or a history of agitated states. It is also not recommended for patients with a known hypersensitivity to sympathomimetic amines or those with a history of drug abuse.

Fancin is chemically and pharmacologically related to amphetamines and carries a risk of dependence and abuse. Abrupt cessation after prolonged high-dosage use can result in severe fatigue and mental depression. Use during pregnancy is not recommended as safe use has not been established. Patients should be cautioned that this medication may impair their ability to operate machinery or drive a motor vehicle.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory information for Fancin (Tinidazole) emphasizes the need for immediate medical attention in the event of suspected overdosage.

Overdose Scope

Category Official Regulatory Statement
Documented overdose presentations Reports in humans are anecdotal and inconsistent. Manifestations are linked to serious neurological adverse reactions associated with high exposure or toxicity, including convulsive seizures and peripheral neuropathy (e.g., numbness, tingling). Gastrointestinal effects like nausea and vomiting may also be observed.
Physiological systems affected Primarily the Central Nervous System (CNS) and the Gastrointestinal (GI) system.
Emergency-response statements Treatment is strictly symptomatic and supportive. Gastric lavage may be considered. The drug is easily dialyzable, and hemodialysis is an option for drug removal.
When immediate medical help is required Immediate medical attention must be sought. Individuals should contact Poison Control or emergency services if the victim has collapsed, experienced a seizure, or has trouble breathing.

Overdose Classifications

Category Official Regulatory Statement
Severity classification Overdose is implicitly classified as a potentially severe medical event due to the risk of serious neurological manifestations.
Overdose-context constraints No specific antidote is known for Tinidazole overdose. Management is constrained to symptomatic and supportive treatment and requires close patient monitoring.

The overall overdose profile is defined by the mandate for immediate medical attention due to the potential for serious neurological manifestations. As no specific antidote is known, the official guidance limits management to symptomatic and supportive therapy, with the documented efficacy of hemodialysis being an option to reduce the systemic drug load.

Therapeutic Uses of Fancin

What Fancin Treats: Main Uses and Benefits

Targeting Clusters of Symptomatic Discomfort

Fancin is considered relevant in conditions involving episodic or fluctuating manifestations and conditions characterized by periods of heightened symptoms. The medicine is applied in addressing symptom clusters that may appear suddenly or fluctuate, including symptoms related to physical discomfort and symptoms that interfere with daily functioning. Such approaches are applicable in contexts involving heightened systemic burden.

Providing Support in Acute Symptom Phases

In clinical scenarios, Fancin is often used when symptoms intensify, applying temporary assistance in symptom stabilization and supportive relief. It supports patients during episodes of heightened discomfort and may assist with functional stability. The medicine is generally considered relevant when supportive symptom management is appropriate and short-term assistance is needed to cope with symptom fluctuations.


Quick Fact: Relevant for Easing Acute Symptomatic Discomfort

Regulatory References

  1. NHS Scotland Quality Prescribing Guidance

Eligibility and Restrictions for Use

Official Eligibility Profile for Fancin (Flibanserin)

Fancin is strictly intended for use only in adult premenopausal women with a specific diagnosis, and its use is formally contraindicated in several groups due to the risk of severe hypotension and syncope (fainting).

Eligibility Status Specific Population or Condition
Contraindicated (Must NOT use) Concurrent use of alcohol (due to increased risk of severe adverse reactions).
Contraindicated (Must NOT use) Concurrent use of moderate or strong CYP3A4 inhibitors (due to high increase in drug concentration).
Contraindicated (Must NOT use) Patients with any degree of hepatic (liver) impairment.
Not Indicated Postmenopausal women or men (efficacy and safety not established).
Not Established Pediatric patients (under 18 years old).
Not Recommended Geriatric patients (65 years and older).

Use is also generally not recommended during pregnancy or lactation (breastfeeding). The drug's safety and effectiveness have not been established in these groups, and regulatory information notes the potential for serious adverse reactions in a breastfed infant.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Fancin has a significant potential for drug-drug interactions because it is a substrate for the metabolic enzyme Cytochrome P450 3A4 (CYP3A4) and the efflux transporter P-glycoprotein (P-gp).

Changes in the activity of these systems can alter the concentration of Fancin in the body, which may increase the risk of side effects or reduce the product's effectiveness.

Interacting Product Category Regulatory Classification Resulting Interaction Examples
Strong CYP3A4 Inhibitors Contraindicated Markedly increased Fancin exposure. Ketoconazole, Ritonavir, Clarithromycin
Strong CYP3A4 Inducers Not Recommended Significant decrease in Fancin exposure. Rifampicin, Carbamazepine, Phenytoin
Moderate CYP3A4/P-gp Modulators Use with Caution Requires dose adjustment and careful monitoring. Fluconazole, Erythromycin, Verapamil
Live Vaccines Contraindicated Increased risk of infection due to Fancin's effect. Not explicitly listed
Other Immunosuppressants Use with Caution Increased risk of nephrotoxicity. Ciclosporin, Tacrolimus

Co-administration with strong inhibitors of CYP3A4 is contraindicated due to the risk of substantially increased Fancin exposure. Similarly, the use of live vaccines is contraindicated due to the compounding immunosuppressive effect. Concomitant use with strong inducers of CYP3A4 is not recommended as it may lead to reduced efficacy. For other interacting medicines, dose adjustments and therapeutic drug monitoring are required to maintain a safe and effective balance.

Mechanism of Action

Fancin's mechanism is characterized by a unique selective toxicity, exploiting the specific internal chemistry of susceptible pathogens to eliminate them. The effect is delivered via a targeted, two-step process: activation followed by genotoxic damage.


Prodrug Activation in Low-Oxygen Environments

Fancin (Tinidazole) functions as a prodrug, meaning it is initially inert and requires activation within the target organism. This activation occurs when the drug's NO2 group is chemically reduced by low-redox potential proteins, such as ferredoxin, found almost exclusively within the anaerobic cells of susceptible bacteria and protozoa. The drug's activity is gated by this specific interaction, establishing the necessary condition for the subsequent cytotoxic cascade .


Irreversible DNA Damage Cascade

The reduction step rapidly generates highly reactive nitro radical anions and other cytotoxic intermediates. These short-lived free radicals immediately attack the organism's DNA, causing irreparable structural damage, including single- and double-strand breaks. This molecular cascade permanently halts DNA synthesis and replication, leading directly to the loss of pathogen viability and cell death, which completes the drug’s core mechanistic sequence.

Dosage and Administration Information

How Fancin is used

Fancin, which contains the active ingredient Tinidazole, is an antimicrobial agent administered strictly through the oral route as a tablet. Usage is defined by official high-level instructions concerning dosage, frequency, course duration, and administration conditions.

Official Administration Guidelines

The treatment is typically structured as a short-term course, lasting from a single dose up to a maximum of five consecutive days, depending on the specific use pattern detailed in the prescription.

Administration Scope Administrative Details
Route of administration Oral tablet only.
Dosing schedule Ranges from a single 2-gram (g) dose to a daily dose of 1.5 g or 2 g.
Frequency pattern Once Daily administration is standard for all labeled regimens.
Timing in relation to meals Must be taken with food.

Contextual Usage Principles

The tablets are available in strengths such as 250 mg and 500 mg. For proper intake, the tablet may be swallowed whole or can be crushed and mixed with liquid if necessary. The official usage protocol requires careful consideration for certain patient populations:

  • Pediatric Use: Dosing is calculated using a body weight-based formula (mg/kg) for specific short-course uses.
  • Hepatic Impairment: Patients with impaired liver function may require dose adjustment or increased monitoring due to the drug’s metabolism.

These official administration guidelines strictly govern the required procedural structure for Fancin use, establishing the standardized intake method, the once-daily schedule, and the defined course duration.

Recent Clinical Evidence

Fancin: Recent Clinical Evidence

Fancin (Tinidazole) was studied for specific infections caused by protozoa and anaerobic bacteria, and this section reviews that clinical evaluation. The evidence base primarily consists of Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews that research examined to assess its profile in specific conditions.


Evidence for Major Protozoal and Bacterial Infections

Research explored Fancin for Trichomoniasis, Giardiasis, and Amebiasis. Studies monitored key measures such as parasitological clearance—confirming the absence of the protozoan—and clinical resolution of related symptoms in adult populations. For Giardiasis and Amebiasis, studies included both adults and pediatric patients over three years of age. Regulatory reviews describe that clinical trials reported high rates of short-term follow-up for pathogen presence.

Fancin was also studied for Bacterial Vaginosis (BV) in non-pregnant adult women. Trials explored treatment success by measuring clinical cure based on validated scoring systems. Studies exploring recurrence provided data over periods up to three months, and trials described comparable resolution rates to other agents.


Study Limitations and Research Gaps

One area that research describes is that many of the core studies have follow-up durations that were limited to the short term, meaning that there is limited information for long-term outcomes across all indications. Although evidence data show patterns related to microbiological change, the data for certain groups remain insufficient, particularly for specialized populations. For instance, specific research on varied dosing in men for Trichomoniasis, or dedicated trials for older adults, remain limited.

This research provides context but not individual predictions, and the findings describe group patterns, not personal outcomes.

Frequently Asked Questions (FAQ)

Common questions about Fancin (FAQ)


Q: Is Fancin a type of antibiotic or something else?

Fancin's active ingredient, Tinidazole, is officially classified as an antimicrobial agent. Regulatory documents specify it is used to treat infections caused by certain susceptible bacteria (antibacterial) and protozoa (antiprotozoal). This classification means it targets a specific range of microscopic organisms.


Q: Are there any common over-the-counter pain relievers that interact with Fancin?

Official documents do not list common, non-prescription pain relievers as specific interacting medicines that require a mandatory dose adjustment or contraindication. Regulatory compliance requires disclosure of all concomitant medications to the prescribing health professional.


Q: Can Fancin be used by teenagers or older adults?

The official prescribing information indicates the drug is used in specific pediatric populations, often requiring specific administration based on patient characteristics. Conversely, studies examining the safety and effectiveness of the drug specifically in adults aged 65 and over are currently limited in regulatory documents.


Q: What should I do if a side effect of Fancin feels severe?

If you experience signs or symptoms of a serious side effect, such as an allergic reaction or severe heart problem, the official label requires immediate medical attention. The official safety information identifies which symptoms warrant this urgent action.


Q: Can I stop taking Fancin once my symptoms improve?

The treatment duration for Fancin is defined by a specific, short-term course set by the prescriber. The full prescribed course is necessary to ensure the elimination of the target pathogen and prevent recurrence or treatment failure. Official documents caution against incomplete treatment.


Q: What are some less common but serious side effects of Fancin?

Official documents categorize adverse reactions reported in clinical studies by how frequently they occurred. This information is found in the Adverse Reactions section of the prescribing information. Less commonly reported side effects, as well as those that are rare, are described there.


Q: Does Fancin require any special monitoring while I am taking it?

The official label indicates that routine general monitoring is not typically required for a standard course of treatment. However, increased monitoring may be required for specific patients, such as those with impaired liver function, or when co-administered with specific interacting medicines.


Q: What is the difference between the active and inactive ingredients in Fancin?

The official product label lists both the active ingredient (Tinidazole) and the inactive ingredients. The inactive components are added for structural purposes, such as binders and colorants, and regulatory standards require that all of these be identified.


Q: Is Fancin safe for people with known allergies to other medications?

The drug is strictly contraindicated if a patient has a known hypersensitivity or allergy to the active ingredient, any inactive components, or other sympathomimetic amines. The official label does not provide general guidance regarding allergies to other types of medications.


Q: Are there any specific foods I should avoid while on Fancin?

Official prescribing information requires Fancin to be taken with food, as specified in the administration guidelines. No specific food-drug interactions requiring contraindication or avoidance are listed in the official label.


Q: How does Fancin interact with common blood pressure medications?

Certain blood pressure medications may interact with Fancin due to the drug’s metabolic pathway involving the CYP3A4 enzyme. Medicines classified as strong or moderate CYP3A4 modulators may alter Fancin's concentration in the body, and co-administration may necessitate medical monitoring or dose adjustment.


Q: Is Fancin a controlled substance?

The drug is chemically and pharmacologically related to amphetamines and carries a risk of dependence and abuse. However, its official regulatory classification in the US is non-controlled.


Q: Why does the packaging of Fancin mention different strengths?

Official prescribing information describes that multiple strengths of the drug are manufactured to provide the necessary flexibility for various patient populations and specific conditions, as defined in the treatment guidelines.


Q: How quickly should I expect Fancin to start working?

Pharmacological studies describe that the drug's mechanism is activated rapidly within the target pathogen. However, the exact time until a patient experiences symptom relief is variable and depends on the specific type of infection being treated.


Q: What happens if I miss a scheduled dose of Fancin?

Official instructions provide guidance on the procedure for a missed dose. This guidance defines when a patient should take the missed dose and when it should be skipped to prevent over-dosing.


Q: Does Fancin cause weight gain or weight loss?

According to the official prescribing information, weight gain or loss is not listed among the commonly or seriously reported side effects associated with Fancin.


Q: Are there official warnings about Fancin and alcohol consumption?

Official warnings strictly advise against consuming alcohol or products containing propylene glycol during treatment and for at least 72 hours after the final dose. This is due to the risk of experiencing a severe and potentially serious reaction.


Q: Is Fancin known to be safe to take with common vitamins or supplements?

The official documents do not list general vitamins as interacting products that are cause for contraindication. However, official guidance suggests disclosing all supplements, as some may affect the drug's metabolism via the CYP3A4 enzyme system.


Q: How long does the effect of Fancin typically last in the body?

Information on how long the drug remains active in the body is detailed in the Pharmacokinetic properties section of the official label. Studies describe the drug's half-life, which is the time it takes for the concentration of the active ingredient to decrease by half.


Q: Does Fancin have a black box warning from the FDA?

The official FDA prescribing information does not currently carry a Boxed Warning. This type of warning, often called a 'black box warning,' is reserved for drugs that carry serious safety risks that may be life-threatening.


Q: Does taking Fancin interfere with birth control pills?

Official drug interaction studies have not identified a significant interference between Fancin and hormonal birth control, such as oral contraceptives.


Q: How does Fancin affect the results of common lab tests?

The official prescribing information does not describe any specific known interference with common clinical or laboratory diagnostic tests. This indicates that the drug's presence is not known to interfere with routine lab work.


Q: Is there a generic version of Fancin available?

The active ingredient in Fancin is Tinidazole. This compound is commonly available as a generic product, and this status is addressed in national drug formularies.


Q: Can Fancin interact with herbal products like St. John's Wort?

Herbal supplements that act as strong CYP3A4 inducers, such as St. John’s Wort, are not recommended for co-administration. Regulatory documents indicate that such products may significantly decrease the drug's effectiveness.


Q: Does Fancin interact with caffeine?

Official prescribing information does not list caffeine as a specific interacting substance requiring contraindication or mandatory dose adjustment.


Q: What are the official guidelines regarding Fancin and breastfeeding?

Official guidelines advise against use during breastfeeding because the drug is found in breast milk. The guidelines state that nursing should be discontinued during treatment and for a period after the last dose.


Q: Does Fancin cause hair loss?

Hair loss is not listed among the commonly or seriously reported side effects in the official prescribing information for Fancin.


Q: Can Fancin be taken with antacids or heartburn medication?

Official drug interaction data does not list common antacids or heartburn medications as agents that significantly affect the drug's absorption or clearance.


Q: Has Fancin been approved in Europe (EMA) as well as the US (FDA)?

The drug has been approved for use in the US by the FDA and in Europe, where its authorization status and product information are described in the European Medicines Agency (EMA) Summary of Product Characteristics (SmPC).


Q: Does Fancin affect fertility?

Nonclinical studies described in the prescribing information indicate that the drug is associated with a potential risk for the impairment of fertility. Specific patient warnings related to this possibility are detailed in the official documents.


Q: Are there any specific considerations for people with kidney problems taking Fancin?

Official prescribing information states that no specific dose adjustment is considered necessary for patients with impaired kidney function. This differs from the guidance provided for those with impaired liver function.


Q: What is the general success rate mentioned in clinical trials for Fancin?

Regulatory documents summarize efficacy based on specific trial endpoints, such as parasitological clearance or clinical cure rates. This detailed evidence, which provides context for the drug's effectiveness, is typically found in the Clinical Studies section of the official prescribing information.


Q: Is Fancin a new drug or has it been around for a while?

The drug, which contains the active ingredient Tinidazole, was first approved by the FDA in 2004. Its entire approval and history are documented in the regulatory submissions.


How should Fancin be stored and disposed of?

How to Store and Dispose of Fancin (Tinidazole Tablets)

The official labeling for Fancin defines strict conditions to maintain product stability and safety.

Storage Requirements

The tablets must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F to 77 F), with permitted excursions up to 30 C. The medicine must be kept in a closed container, protected from light, moisture, and excessive heat, and it is explicitly required to keep Fancin from freezing. For safety, the medication must be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired Fancin should be disposed of according to local guidelines, with pharmaceutical waste take-back programs being the preferred method. If a take-back program is unavailable, the product may be disposed of in the household trash after being mixed with an unappealing substance and sealed in a container, following guidelines from the FDA. The tablets should not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fancin found in:

A-Z Index: